SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-104090
Filing Date
2024-09-05
Accepted
2024-09-05 17:11:01
Documents
11
Period of Report
2024-08-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A tlis-20240829.htm   iXBRL 8-K/A 54538
  Complete submission text file 0000950170-24-104090.txt   201537

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tlis-20240829.xsd EX-101.SCH 47767
13 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20240829_htm.xml XML 4897
Mailing Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607
Business Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40047 | Film No.: 241282144
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)